First European Varian Medical Systems Trilogy™ Installation Introduces Advanced Cancer Treatments to Portugal | Varian

{ "pageType": "news-article", "title": "First European Varian Medical Systems Trilogy™ Installation Introduces Advanced Cancer Treatments to Portugal", "articleDate": "23 de September de 2005", "introText": "", "category": "Oncology" }

First European Varian Medical Systems Trilogy™ Installation Introduces Advanced Cancer Treatments to Portugal

LISBON, Portugal, Sept. 23 /PRNewswire-FirstCall/ -- Some of the world's most advanced radiotherapy treatments will become available to cancer patients at a leading clinic in Portugal with Europe's first installation of the state-of-the-art Trilogy™ medical linear accelerator. Using the Trilogy device, doctors at Clinica Quadrantes in Lisbon will be able to offer cancer patients more targeted treatments using new methods including intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT) and stereotactic radiosurgery (SRS).

A fully-accessorized Varian Medical Systems Trilogy medical linear accelerator is the most versatile machine in the world with the capability of offering all standard radiation therapies as well as the most advanced treatments that make it possible to concentrate more dose on tumors while protecting surrounding healthy tissue. It is expected to help doctors to improve cure rates for patients while reducing treatment complications.

Dr. Luis Lebre, clinical director at Clinica Quadrantes, says, "We acquired the Trilogy accelerator because we always strive to set standards in radiotherapy and radiosurgery treatments in Portugal. This means cancer patients in this country will finally be able to receive these more targeted treatments and shows just how far radiotherapy capabilities have developed in Portugal in the last five years."

He said the acquisition of the Trilogy accelerator came as a result of a close collaboration between the clinic's radiation oncologists, neurosurgeons and medical physicists. The new medical linear accelerator makes it possible to control malignant metastatic outbreaks anywhere in the body using stereotactic treatments that involve delivering higher doses of radiation to smaller areas with more precision in just one to five treatment sessions.

"Trilogy is the first practical, clinically-viable linear accelerator that is capable of delivering all forms of external-beam radiation therapy," said Walter Frei, head of Varian's Oncology Systems business in Europe. "It enables doctors to choose and use the most appropriate treatment modality for treating cancer in the body or the head and neck, and to deliver the full spectrum of treatments, all on one machine in a single room."

Designed for more rapid and precise treatments than is possible with conventional accelerators, the Trilogy accelerator can be equipped with Varian's Dynamic Targeting™ IGRT accessories for improved treatment precision, including the On-Board Imager™, which gives doctors radiographic (two-dimensional), fluoroscopic (time-lapse), and cone-beam CT (three-dimensional) images for seeing and targeting tumors more precisely.

The On-Board Imager is already installed on Varian Trilogy and Clinac® medical linear accelerators at more than 80 cancer treatment centers around the globe. Within Europe, Varian's IGRT tools based on the On-Board Imager are in clinical use and available at Karolinska Institute in Stockholm, Sweden, Hirslanden Klinik in Aarau, Switzerland, the University Hospital in Aarhus, Denmark, Haukeland University in Bergen, Norway, the Clatterbridge Oncology Centre near Liverpool, UK, and others.

As well as the Trilogy accelerator, Clinica Quadrantes treats patients using a Varian Clinac 2100CD linear accelerator and an Acuity imaging system for treatment planning and simulation. Additional Clinac and Acuity devices were recently ordered for installation in the clinic's new satellite center at Faro, on the Algarve, which will enable patients from the south of Portugal to receive state-of-the-art cancer treatments without having to travel to Lisbon.

About Varian Medical Systems

Varian Medical Systems, Inc., (NYSE: VAR) of Palo Alto, California is the world's leading supplier of equipment and software for treating cancer. The company is also a premier supplier of components including X-ray tubes and flat-panel detectors for medical, scientific, and industrial imaging. Varian Medical Systems employs approximately 3,280 people who are located at manufacturing sites in North America and Europe and in its 55 sales and support offices around the world. The company operates manufacturing and engineering centres in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. Additional information is available on the company's web site at

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.

CONTACT: Neil Madle of Varian Medical Systems, +44-7786-526068.

SOURCE: Varian Medical Systems, Inc.

Web site: